MIF and neoplasm: A more direct link between MIF and angiogenesis was demonstrated by the group of R. Bucala, who showed that the administration of an anti-MIF monoclonal antibody to B-lymphoma tumor-bearing mice significantly reduced the tumor vascularization compared with the group receiving an isotype control.